ArticleFrontiers in microbiology2025
Zhi-zi-chi decoction exerts hypnotic effect through gut-brain axis modulation in insomnia mice.
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evidence-based acupuncture: Methodological insights and challenges in gastroenteroscopy recovery research.World journal of gastroenterology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Insomnia, a frequently encountered sleep disorder, boasts a high prevalence rate on a global scale. Currently, Western medications are widely used for its treatment; however, they may cause adverse effects such as dependence and daytime drowsiness. Traditional Chinese medicine (TCM) offers a safer alternative. Zhi-zi-chi Decoction (ZZCD), composed of Methods: A PCPA-induced mice model of insomnia was used to evaluate the therapeutic effects of ZZCD. Behavioral tests, neurotransmitter assays, ELISA for HPA axis and inflammatory markers, 16S rDNA gut microbiota sequencing, and histological analyses of brain and colon tissues were performed. Results: ZZCD significantly improved sleep and reduced anxiety-like behavior. It restored GABA and 5-HT levels while lowering GLU and DA, normalized HPA axis activity, reduced inflammatory cytokines, and increased beneficial gut bacteria such as Conclusion: ZZCD alleviates insomnia by modulating the gut-brain axis, rebalancing neurotransmitters, and restoring microbial homeostasis. These findings support its use as a safe and effective treatment for insomnia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.